Amiot M - Search Results

1

A highly sensitive quantitative bioassay for human interleukin-11.

Lu ZY, Zhang XG, Gu ZJ, Yasukawa K, Amiot M, Etrillard M, Bataille R, Klein B. Lu ZY, et al. Among authors: amiot m. J Immunol Methods. 1994 Jul 12;173(1):19-26. doi: 10.1016/0022-1759(94)90278-x. J Immunol Methods. 1994. PMID: 8034982

2

A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy.

Bataille R, Robillard N, Pellat-Deceunynck C, Amiot M. Bataille R, et al. Among authors: amiot m. Immunol Rev. 2003 Aug;194:105-11. doi: 10.1034/j.1600-065x.2003.00039.x. Immunol Rev. 2003. PMID: 12846811 Review.

3

The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.

Barillé S, Bataille R, Amiot M. Barillé S, et al. Among authors: amiot m. Eur Cytokine Netw. 2000 Dec;11(4):546-51. Eur Cytokine Netw. 2000. PMID: 11125296 Free article. Review.

4

Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule.

Puthier D, Thabard W, Rapp M, Etrillard M, Harousseau J, Bataille R, Amiot M. Puthier D, et al. Among authors: amiot m. Br J Haematol. 2001 Feb;112(2):358-63. doi: 10.1046/j.1365-2141.2001.02575.x. Br J Haematol. 2001. PMID: 11167829 Free article.

5

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines.

Moreaux J, Klein B, Bataille R, Descamps G, Maïga S, Hose D, Goldschmidt H, Jauch A, Rème T, Jourdan M, Amiot M, Pellat-Deceunynck C. Moreaux J, et al. Among authors: amiot m. Haematologica. 2011 Apr;96(4):574-82. doi: 10.3324/haematol.2010.033456. Epub 2010 Dec 20. Haematologica. 2011. PMID: 21173094 Free PMC article.

6

Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells.

Chiron D, Maïga S, Surget S, Descamps G, Gomez-Bougie P, Traore S, Robillard N, Moreau P, Le Gouill S, Bataille R, Amiot M, Pellat-Deceunynck C. Chiron D, et al. Among authors: amiot m. Blood Cancer J. 2013 Jun 7;3(6):e120. doi: 10.1038/bcj.2013.18. Blood Cancer J. 2013. PMID: 23749045 Free PMC article.

7

Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin.

Barillé S, Collette M, Bataille R, Amiot M. Barillé S, et al. Among authors: amiot m. Blood. 1995 Oct 15;86(8):3151-9. Blood. 1995. PMID: 7579410 Free article.

8

The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells.

Juge-Morineau N, François S, Puthier D, Godard A, Bataille R, Amiot M. Juge-Morineau N, et al. Among authors: amiot m. Br J Haematol. 1995 Jul;90(3):707-10. doi: 10.1111/j.1365-2141.1995.tb05605.x. Br J Haematol. 1995. PMID: 7647014

9

CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.

Pellat-Deceunynck C, Amiot M, Robillard N, Wijdenes J, Bataille R. Pellat-Deceunynck C, et al. Among authors: amiot m. Cancer Res. 1996 Apr 15;56(8):1909-16. Cancer Res. 1996. PMID: 8620513

10

Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone.

Puthier D, Bataille R, Barillé S, Mellerin MP, Harousseau JL, Ponzio A, Robillard N, Wijdenes J, Amiot M. Puthier D, et al. Among authors: amiot m. Blood. 1996 Dec 15;88(12):4659-66. Blood. 1996. PMID: 8977259 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters